Gillian Merron to oversee the UK industry
This article was originally published in Scrip
Gillian Merron has been appointed the UK's minister of state for public health at the department of health, a post in which she will be responsible for overseeing the pharmaceuticals industry and the medicines regulator, the medicines and healthcare products regulatory agency.
You may also be interested in...
Sweden’s mid-sized pharmaceutical company, Swedish Orphan Biovitrum, has expanded into hematology and strengthened its immunology business, growing its top and bottom lines in 2019.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
An interim analysis of the Phase III KEYNOTE-355 study in triple-negative breast cancer patients reports that first-line pembrolizumab combined with chemotherapy has met the PFS primary endpoint, but Merck & Co is still a long way behind Roche’s Tecentriq in the additional indication.